$BFRI 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Other Events Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United States to treat a skin cancer, creating an additional growth opportunity for Biofrontera’s photodynamic therapy plat...
13 Aug 2026	8-K: Results of Operations and Financial Condition
17 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Results of Operations and Financial Condition
19 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Regulation FD Disclosure
26 Feb 2026	8-K: Other Events
09 Feb 2026	8-K: Regulation FD Disclosure
13 Jan 2026	8-K: Results of Operations and Financial Condition
07 Jan 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
13 Nov 2025	8-K: Results of Operations and Financial Condition
10 Nov 2025	8-K: Other Events
07 Nov 2025	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
24 Oct 2025	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more
23 Oct 2025	8-K: Regulation FD Disclosure
19 Sep 2025	8-K: Submission of Matters to a Vote of Security Holders
13 Aug 2025	8-K: Results of Operations and Financial Condition
11 Aug 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
01 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
30 Jun 2025	8-K: Regulation FD Disclosure

Comments